Evidence map›Paper›PMID 34214626›Full record

SynthesisJournal of clinical epidemiology2021

Reporting of prognostic clinical prediction models based on machine learning methods in oncology needs to be improved.

Paula Dhiman, Jie Ma, Constanza Andaur Navarro, Benjamin Speich, Garrett Bullock, Johanna Aa Damen, Shona Kirtley, Lotty Hooft, Richard D Riley, Ben Van Calster and 2 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of clinical epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 12 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 12 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Paula DhimanCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. Electronic address: paula.dhiman@csm.ox.ac.uk.
Jie MaCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Constanza Andaur NavarroJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Benjamin SpeichCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK; Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland.
Garrett BullockNuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Johanna Aa DamenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Shona KirtleyCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Lotty HooftJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Richard D RileyCentre for Prognosis Research, School of Medicine, Keele University, Staffordshire, UK. ST5 5BG.
Ben Van CalsterDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; EPI-centre, KU Leuven, Leuven, Belgium.
Karel G M MoonsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Gary S CollinsCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
University Medical Center Utrecht · NLNuffield Orthopaedic Centre · GBUniversity of Oxford · GBKeele University · GBKU Leuven · BEOxford BioMedica (United Kingdom) · GBUniversity Hospital of Basel · CHUtrecht University · NL

Funding

Cancer Research UK 27294Cancer Research UK C49297/A27294Department of Health
6 · The paper itself

Abstract

objectiveEvaluate the completeness of reporting of prognostic prediction models developed using machine learning methods in the field of oncology. STUDY DESIGN AND

settingWe conducted a systematic review, searching the MEDLINE and Embase databases between 01/01/2019 and 05/09/2019, for non-imaging studies developing a prognostic clinical prediction model using machine learning methods (as defined by primary study authors) in oncology. We used the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) statement to assess the reporting quality of included publications. We described overall reporting adherence of included publications and by each section of TRIPOD.

resultsSixty-two publications met the inclusion criteria. 48 were development studies and 14 were development with validation studies. 152 models were developed across all publications. Median adherence to TRIPOD reporting items was 41% [range: 10%-67%] and at least 50% adherence was found in 19% (n=12/62) of publications. Adherence was lower in development only studies (median: 38% [range: 10%-67%]); and higher in development with validation studies (median: 49% [range: 33%-59%]).

conclusionReporting of clinical prediction models using machine learning in oncology is poor and needs urgent improvement, so readers and stakeholders can appraise the study methods, understand study findings, and reduce research waste.

Indexed as

Guidelines as TopicMedical OncologyModels, StatisticalPrognosisBiomedical ResearchHumansMachine LearningResearch DesignMachine learningPredictionReporting

Identifiers

PMID34214626
PMCPMC8592577
OpenAlexW3173574091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.